SCL Science

SCL Science Inventory Turnover

The Inventory Turnover Ratio of SCL Science (246960.KQ) as of Nov 5, 2026 is 12.75. In the previous year, Inventory Turnover Ratio was 3.01 — a change of 323.75% (higher).

Inventory Turnover

12.75

YoY

323.75%

Last updated:

Inventory Turnover Ratio of SCL Science is 2025 12.75 . Inventory Turnover Ratio of SCL Science was 2024 3.01 . It decreases by 323.75% higher compared to the previous year.

The SCL Science Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2018
1.56 KRW
Jan 1, 2019
1.93 KRW
Jan 1, 2020
1.64 KRW
Jan 1, 2021
2.18 KRW
Jan 1, 2022
0.99 KRW
Jan 1, 2023
4.20 KRW
Jan 1, 2024
3.01 KRW
Jan 1, 2025
12.75 KRW
The SCL Science Inventory Turnover history
YEARInventory TurnoverYoY
12.75+323.75%
3.01-28.44%
4.20+326.30%
0.99-54.72%
2.18+32.45%
1.64-14.90%
1.93+23.74%
1.56+24.55%
1.25-30.42%
1.80—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCL Science Stock analysis

What does SCL Science do? SCL Science Inc, listed on the Korean stock exchange with ticker 246960.KQ and ISIN KR7246960009, is a healthcare company headquartered in Seoul, South Korea. The company went public on February 1, 2019, as indicated by its IPO date. SCL Science Inc operates within the healthcare sector, focusing on the development and commercialization of medical products. According to the provided information, the company manufactures and sells hemostatic medical agents, which are used to control bleeding in medical procedures. The company's products include medical hemostats and sealants that utilize biomimetic technology, a technology inspired by natural biological processes. The company's website is innotherapy.com, which may provide further details about its products and services. SCL Science Inc is based in Seoul, South Korea, and its primary business activities are centered around the healthcare industry, specifically in the field of hemostatic solutions. The company's focus on biomimetic technology suggests an innovative approach to developing medical products that mimic natural biological mechanisms. The company's operations are likely aimed at providing medical professionals with effective tools for managing bleeding during surgical and other medical procedures. The company's market presence is within South Korea, though it may have international reach through its website and product distribution channels. The information provided does not include details on the company's revenue, market share, or specific competitors, nor does it mention any acquisitions or key personnel beyond the general description of its business activities. SCL Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCL Science stock

Inventory Turnover Ratio of SCL Science is 12.75 in 2025.

Inventory Turnover Ratio of SCL Science changed from 3.01 to 12.75, representing a 323.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio SCL Science since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's SCL Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — SCL Science

All Key Metrics — SCL Science